Century Therapeutics, Inc. (IPSC) vs Prelude Therapeutics Incorporated (PRLD)
Century Therapeutics, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Century Therapeutics, Inc. and Prelude Therapeutics Incorporated are of similar size ($318.4M and $306.0M). Century Therapeutics, Inc. has the higher net margin (0.00% vs −269.8%) and the lower return on invested capital (−64.9% vs 0.00%). Across the 14 metrics below, Century Therapeutics, Inc. leads on 10 and Prelude Therapeutics Incorporated on 4.
Valuation
Profitability
| Metric | IPSC | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (300.56%) | 0.00% |
| Net margin | 0.00% | (269.75%) | 0.00% |
| Free cash flow margin | 0.00% | (148.30%) | 0.00% |
| Return on equity | (49.65%) | (57.73%) | (57.72%) |
| Return on assets | (38.41%) | (39.76%) | (49.22%) |
| Return on invested capital | (64.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack